Inactivation of TGFβ receptors in stem cells drives cutaneous squamous cell carcinoma

Patrizia Cammareri1, Aidan M Rose2, David F Vincent1

  • 1Wnt Signaling and Colorectal Cancer Group, Cancer Research UK Beatson Institute, Institute of Cancer Sciences, Glasgow University, Garscube Estate, Switichback Road, Glasgow G61 1BD, UK.

Nature Communications
|August 26, 2016
PubMed

Insights

Oncogenic BRAF inhibitor treatment can cause skin cancer (cSCC) due to pathway activation. Mutations in TGFBR1/2 and loss of TGFβ signaling in stem cells drive cSCC development, indicating these stem cells are key to skin tumorigenesis.

Area of Science:

  • Dermatology
  • Oncology
  • Molecular Biology

Background:

  • Melanoma patients on BRAF inhibitors can develop cutaneous squamous cell carcinoma (cSCC).
  • This is driven by paradoxical RAS/RAF/MAPK pathway activation.
  • TGFβ signaling plays a role in skin homeostasis.

Purpose of the Study:

  • To identify genetic drivers of vemurafenib-induced cSCC.
  • To investigate the role of TGFβ signaling in skin stem cells in cSCC development.
  • To explore the cell of origin for cSCC.

Main Methods:

  • Analysis of human vemurafenib-induced skin lesions and sporadic cSCC for mutations.
  • Functional studies of TGFβ signaling in mouse models.
  • Genetic manipulation of stem cells (LGR5+ve) in mice.

Main Results:

  • Frequent TGFBR1 and TGFBR2 mutations were found in human cSCC lesions.
  • These mutations ablate canonical TGFβ Smad signaling.
  • Combined MAPK hyperactivation or Tp53 mutation with TGFβ signaling loss in LGR5+ve stem cells rapidly induced cSCC in mice.

Conclusions:

  • LGR5+ve stem cells are identified as potential cells of origin for cSCC.
  • Aberrant RAS/RAF/MAPK pathway activation or Tp53 mutation, alongside TGFβ signaling loss, are critical events in skin tumorigenesis.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.8K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.6K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
6.0K
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.5K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.2K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.0K